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Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells Erica Novo 1 Background & Aims Liver fibrogenesis is sustained by myofibroblast-like cells originating from hepatic stellate cells (HSC/MFs), portal fibroblasts or bone marrow-derived cells, including mesenchymal stem cells (MSCs). Herein, we investigated the mechanistic role of intracellular generation of reactive oxygen species (ROS) and redox-sensitive signal transduction pathways in mediating chemotaxis, a critical profibrogenic response for human HSC/MFs and for MSC potentially engrafting chronically injured liver.
Methods
Intracellular generation of ROS and signal transduction pathways were evaluated by integrating morphological and molecular biology techniques. Chemokinesis and chemotaxis were evaluated by wound healing assay and modified Boyden's chamber assay, respectively. Additional in vivo evidence was obtained in human specimens from HCV-related cirrhosis.
Results
Human MSCs and HSC/MFs migrate in response to a panel of polypeptide chemoattractants and extracellularly generated superoxide anion. All polypeptides induced a NADPH-oxidase-dependent intracellular rise in ROS, resulting in activation of ERK1/2 and JNK1/2. Moreover, menadione or 2,3-dimethoxy-1,4-naphthoquinone, which generate intracellular superoxide anion or hydrogen peroxide, respectively, induced ERK1/2 and JNK1/2 activation and migration. JNK1 activation was predominant for migration as shown by specific silencing. Finally, activation of ERK1/2 and JNK1/2 was found in extracts obtained from HSC/MFs during the course of an oxidative stress-mediated model of liver injury and phosphorylated JNK1/2 isoforms were detected in α-smooth muscle actinpositive myofibroblasts lining fibrotic septa in human cirrhotic livers.
Conclusions
Intracellular generation of ROS, through activation of specific signaling pathways, is a critical event for directional migration of HSC/MFs and MSCs. 
Abbreviations

Introduction
Fibrotic progression of chronic liver diseases (CLDs) is sustained by hepatic populations of myofibroblast-like cells (MFs) that originate mainly from activation of hepatic stellate cells (HSC) and portal (myo)fibroblasts [1] , [2] , [3] , [4] and [5] or, to a lesser extent, through epithelial to mesenchymal transition (EMT) of hepatocytes and/or cholangiocytes [3] , or circulating and bone marrow-derived mesenchymal stem cells (MSCs) or fibrocytes [4] and [5] engrafting chronically injured liver. Most of our knowledge derives from studies on fully activated, MF-like HSC (HSC/MFs) and their phenotypic responses (proliferation, increased synthesis of ECM, and pro-inflammatory mediators, migration, contractility) that are initiated and/or sustained by growth factors, chemokines, adipokines [1] , [2] , [3] , [4] and [5] , reactive oxygen species (ROS), and other mediators [6] .
Whatever their origin be, MFs ability to migrate towards the site of injury and to align with nascent and established fibrotic septa represents a relevant pro-fibrogenic feature which, in turn, may be critical in recruiting circulating MSCs and driving their migration once differentiated into a MF-like phenotype. Induction of HSC/MFs chemotaxis is stimulated by polypeptides overexpressed during CLDs, including platelet-derived growth factor (PDGF), monocyte chemoattractant protein-1 (MCP-1 or CCL2) [7] , angiotensin II (AT-II) [8] , vascular-endothelial growth factor (VEGF), angiopoietin-1 [9] , and ROS like superoxide anion [10] and [11] . PDGF, the best characterized and most potent chemoattractant for HSC/MFs, is also active on human MSC in their fibroblast-like and α-SMA-positive phenotype [12] . Moreover, chemoattractants operate by activating Ras/ERK signaling, with only PDGF being able to activate PI-3 K/c-Akt signaling [1] , [2] , [6] , [7] , [8] , [9] , [10] , [11] and [12] .
In this study, we show that all effective stimuli for profibrogenic human HSC/MFs and bone marrow-derived fibroblast-like MSCs require, as a common critical step, intracellular generation of ROS in order to trigger chemotaxis through a mechanism that involves redox-sensitive activation of ERK1/2 and JNK1/2. 
Materials and methods
Materials
Isolation and culture of hepatic stellate cells and mesenchymal stem cells
Human HSC were isolated and characterized [13] from surgical wedge sections of at least three different human livers not suitable for transplantation after obtaining the approval of the Human Research Review Committee (University of Florence). HSC were cultured as previously described [9] and [11] , used between passages 4 and 7 (fully activated HSC/MFs), plated to obtain the desired sub-confluence level, and then left for 24 h in serum-free Iscove's medium to have cells at the lowest level of spontaneous proliferation.
Procedures for isolation of rat HSCs have also been extensively described [14] .
Bone marrow cells were obtained from human donors after informed consent. Aliquots of
Animal experiments
Male adult Wistar rats, initial weight 200-220 g, receiving human care and with experimental protocols performed according to national and local guidelines, were fed a standard pelleted diet and water ad libitum. Acute liver injury was induced by single oral treatment with carbon tetrachloride (CCl 4 ) and animals were sacrificed from 24 to 96 h, as previously described [16] .
Cell migration and chemotaxis
Non-oriented migration (chemokinesis) and chemotaxis of human HSC/MFs and human MSCs were evaluated by performing the wound healing assay (20 h of incubation) or the modified Boyden's chamber assay (6 h of incubation), as described [9] , [11] and [16] .
Molecular biology procedures
Total cell extracts were subjected to SDS-PAGE on 10% or 7.5% acrylamide gels. The blots were incubated with desired primary antibodies and then with peroxidase-conjugated anti-mouse or anti-rabbit immunoglobulins in Tris-buffered saline-Tween containing 2%
(w/v) non-fat dry milk [9] and [16] and developed with the enhanced chemiluminescence reagents according to manufacturer's instructions.
Target siRNA sequences for down-regulation of human JNK isoforms are:
(1) (5′-GAAAGAATGTCCTACCTTCT-3′), found in both JNK1 mRNA (nucleotide 393-412) and JNK2 mRNA (nucleotide 425-444) [17] .
(2)
(5′-AAGAGAGCTTATCGTGAACTT-3′) found in JNK2 mRNA. siRNAs and related non-silencing controls were synthesized by Qiagen-Xeragon (Germantown, MD, USA). For transfection, the Amaxa nucleofection technology (Amaxa; Koln, Germany) was employed [18] . JNK1/2 protein levels were analyzed by Western blot analysis 96 h after transfection.
JNK activity in HSC lysates was detected using recombinant activating transcription factor-2 (rATF2) as substrate [19] .
Detection of intracellular and in vivo levels of ROS Intracellular levels of ROS were detected by means of the semi quantitative 2′,7′dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescence technique, as previously detailed [20] , in cells exposed to the desired stimulus for 15 min or to 50 μM hydrogen peroxide (H 2 O 2 , positive control).
In vivo levels of ROS or 4-hydroxynonenal (HNE) were detected [16] and [21] on extracts obtained from the liver of control rats as well as of rats treated with a single dose of CCl 4 and then sacrificed 24, 48 and 72 h after treatment.
Morphological analysis
Indirect immunofluorescence was performed on liver cryostat sections from human biopsies from HCV cirrhotic patients (6 μm thick), as described [9] . 
Statistical analysis
Data in bar graphs represent means ± SEM, and were obtained from average data of at 
Results
Migration of human HSC/MFs and MSCs in response to chemoattractants HSC/MFs (Fig. 1A) , migrated significantly in response to PDGF-BB, MCP-1, VEGF, and superoxide anion, whereas hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), and stromal cell-derived factor 1 (SDF-1 or CXCL12) were ineffective. Human Based on preliminary results, PDGF-BB, MCP-1, and VEGF were used throughout the study as positive stimuli to investigate in detail the involvement of ERK1/2 and JNK1/2.
Pre-treatment with PD98095, pharmacological inhibitor of ERK1/2 upstream kinase MEK-1, inhibited chemokinesis and chemotaxis in HSC/MFs, as previously reported, [6] , [7] , [8] , [9] , [10] and [11] and MSCs; similar results were obtained by pretreating cells with the pharmacological inhibitor of JNK1/2 SP600125 (Supplementary Fig.   2A and B) . In preliminary experiments we then selected an siRNA that significantly down-regulated 46 kDa JNK1/2 isoforms in both cell types, and resulted in a significant decrease in JNK1/2 phosphorylation in response to PDGF-BB, chosen as a reference chemoattractant ( Fig. 3A and B ). When HSC/MFs and MSCs silenced for JNK1/2 were then exposed to PDGF-BB, VEGF, and MCP-1, chemotaxis was either significantly reduced (as for PDGF-BB) or almost abolished ( Fig. 3A and B) as compared with cells carrying non-silencing siRNA (NsC). Moreover, as an additional proof of principle, experiments performed in mouse embryo fibroblasts from JNK1/2 double knock-out mice (MEF cells, Supplementary Fig. 3B ) versus wild type fibroblasts revealed that only few MEF cells (15-20% in a typical experiment) migrated in response to PDGF-BB. To further explore the role of different isoforms we next employed siRNAs designed to silence JNK1 or JNK2 isoforms in both cell types and in these conditions we found that, running both WHA and chemotaxis assays in response to PDGF-BB, the contribution of JNK1 isoforms to migration was more significant (Fig. 3C and D) . Fig. 4A and B) , a finding significantly prevented by pre-treating cells with the more specific NADPH-oxidase pharmacological inhibitor apocynin ( Fig. 4C and D) . Accordingly, apocynin also significantly inhibited polypeptide-induced chemokinesis and chemotaxis in HSC/MFs ( Fig. 5A ) and in MSCs (Fig. 5B ). DPI and apocynin, at the experimental dose used, were completely ineffective on parameters of either necrotic or apoptotic cell death ( Supplementary Fig. 4C and D) . Supplementary Fig. 5A-C) . Since homologous results were found for MSCs (data not shown) MEN and DMNQ were employed in all experiments at 0.1 μM, a non-toxic dose resulting in intracellular generation of ROS in both cell types ( Fig. 4A and B ).
Exposure of HSC/MFs and MSCs to MEN or DMNQ triggered an early and significant
increased phosphorylation of ERK1/2 and JNK1/2 ( Fig. 6A and B) as well as chemokinesis and chemotaxis that were again prevented by PD98095 ( Supplementary Fig. 6A and B) .
Moreover, in cells silenced for JNK1/2 chemotaxis stimulated by MEN and DMNQ was significantly decreased (Fig. 6C and D) , as compared to cells transfected with a nonsilencing RNA (NsC). 
Increased generation of ROS and JNK activity in vivo
In order to evaluate whether intracellular generation of ROS and JNK activation were likely to occur in vivo, activation of JNK1/2 was first investigated in cell extracts obtained from freshly isolated rat HSC obtained at different time points after administration of a single dose of CCl 4 , a model of acute liver injury in which oxidative stress is up-regulated from early time points (2-6 h) to 48-72 h [17] and [19] , as shown by hepatic levels of ROS and 4-hydroxynonenal ( Fig. 7A and B ). HSC lysates from CCl 4 -injured livers, in which activation of ERK1/2 was already reported [22] , were characterized by a very significant increase of JNK activity (24 h) and (6 h) heme oxygenase 1 (HO-1) , a cytoprotective enzyme that is considered a marker of ongoing oxidative stress ( Fig. 7 C and D) . HO-1 protein levels were still elevated until 48 h and declined significantly starting from 72 h (data not shown). 
Discussion
Migration in response to chemoattractant polypeptides or other mediators generated during CLDs represents a distinctive feature of HSC/MFs and hepatic MFs of different origin [1] , [2] , [3] , [4] and [5] , leading these cells to align with inflammatory cells along fibrotic septa during fibrogenic progression. The present study provides the following major Migration of human HSC/MFs in response to chemoattractants was already reported to involve the Ras/ERK pathway [1] , [3] , [7] , [8] and [9] , with only PDGF [1] , [3] and [7] being able to activate the PI-3 K/c-Akt pathway. The involvement of a more complex scenario was first suggested by studies showing that either skin fibroblasts [23] or rat HSC [24] migrated in response to PDGF-BB by a pathway involving transient activation of JNK isoforms, a scenario that our study revealed to be common to all effective polypeptide chemoattractants.
Since the involvement of the Ras/ERK pathway was already characterized in the literature, we then focused on the role of intracellular generation of ROS and of transient activation of JNK1/2. JNKs are redox sensitive serine/threonine protein kinases involved in a number of "stressful" conditions, including inflammation, differentiation, apoptosis, and insulin resistance [25] and [26] as well as in the growth factordependent regulation of migration and epithelial morphogenesis [27] . A mechanistic relationship between polypeptidedependent JNK1/2 activation and migration was unequivocally shown by silencing an evolutionary conserved sequence common to both JNK1 and JNK2 isoforms or in fibroblasts obtained from mouse embryos with targeted deletion of both JNK isoforms.
Since polypeptide-dependent activation of JNK1/2 was an early (within 15 min), transient (i.e., unable to induce apoptosis) and specific event, being mostly limited to 46 kDa isoforms, silencing of both JNK1 and JNK2 was the starting reasonable experimental choice because: (a) alternative splicing of JNK1 and JNK2 leads to eight different isoforms of 54 and 46 kDa, the latter molecular weight including JNK1α1, JNK1β1, JNK2α1, and JNK2β1 isoforms [25] ; (b) the combined deficiency for both isoforms in double knock out mice is lethal in embryo development. However, it should be noted that under conditions of specific selective silencing, we observed that JNK1 silencing was more effective in inhibiting migration and chemotaxis, suggesting a prevalent role for JNK1 according to recent published data [28] and [29] .
In our study, a critical pro-migratory role for ROS-mediated JNK activation was outlined by the following in vitro findings: (1) [31] , was detected at an early time point (i.e., within 24 h) in cell extracts obtained from rat HSC/MFs isolated by acutely injured livers suggesting that "in vivo" HSC/MFs were indeed exposed to oxidative stress.
In conclusion, migration/chemotaxis of human HSC/MFs and MSCs stimulated by polypeptides critically requires NADPH-oxidase dependent increased generation of intracellular ROS and the consequent activation of JNK1/2 isoforms in addition to activation of Ras/ERK signaling. Moreover, ROS released in the context of chronic liver injury by damaged hepatocytes or activated inflammatory cells may induce migration/chemotaxis in both cell types that have been shown to contribute to liver fibrogenesis [1] , [2] , [3] and [4] . The overall scenario emerging from the present study, which is fully in agreement with the recent hypothesis of JNK being involved in HSC activation and fibrogenesis [29] , further suggests JNK as a common putative therapeutic target for antioxidants and/or small molecules such as protein kinase inhibitors.
